Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Risk of Developing Acute Myeloid Leukaemia in Patients With Ewing's Sarcoma: A SEER-based Study

NCT06659224 is registered in ClinicalTrials.gov with asmaa salama ibrahim as lead sponsor.

NCT NCT06659224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06659224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Risk of Developing Acute Myeloid Leukaemia in Patients With Ewing's Sarcoma: A SEER-based Study
Lead sponsor
asmaa salama ibrahim
Phase
Observational
Overall status
Completed
Start date
January 1, 2000
Completion date
December 30, 2021
Enrollment
2,631 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml), ewing sarcoma